PRODUCT DETAILS

GALVUS MET-50MG/500MG-15 TABLETS | Vildagliptin + Metformin

GALVUS MET-50MG/500MG-15 TABLETS combines Vildagliptin 50 mg and Metformin 500 mg to help improve blood sugar control in adults with type 2 diabetes alongside diet and exercise.

H1 (20–50 characters)

GALVUS MET-50MG/500MG-15 TABLETS

GALVUS MET-50MG/500MG-15 TABLETS (Vildagliptin 50 mg + Metformin 500 mg): Comprehensive Guide and Benefits

Introduction to GALVUS MET-50MG/500MG-15 TABLETS (Vildagliptin 50 mg + Metformin 500 mg)

GALVUS MET-50MG/500MG-15 TABLETS (Vildagliptin 50 mg + Metformin 500 mg): A DPP-4 Inhibitor and Biguanide Combination for Type 2 Diabetes

GALVUS MET-50MG/500MG-15 TABLETS is a prescription-only antidiabetic medicine containing Vildagliptin 50 mg and Metformin Hydrochloride 500 mg. This combination is indicated for adults with type 2 diabetes mellitus to improve glycaemic control when diet, exercise, and metformin alone are insufficient or when patients are already taking both medicines separately.

Vildagliptin increases glucose-dependent insulin release by inhibiting the enzyme DPP-4, while metformin decreases glucose production by the liver, reduces intestinal glucose absorption, and improves insulin sensitivity. Together, these complementary mechanisms help control blood glucose levels and reduce the risk of long-term diabetes complications. Treatment should be used under medical supervision with regular monitoring of blood glucose, kidney function, and overall diabetes management.

Key Benefits of GALVUS MET-50MG/500MG-15 TABLETS (Vildagliptin 50 mg + Metformin 500 mg)

Helps improve blood glucose control in adults with type 2 diabetes.

Combines two complementary antidiabetic medicines in one tablet.

Supports better glycaemic management alongside diet and exercise.

May help reduce the risk of diabetes-related complications through improved glucose control.

Convenient fixed-dose combination that may simplify treatment.

How GALVUS MET-50MG/500MG-15 TABLETS (Vildagliptin 50 mg + Metformin 500 mg) Works

Vildagliptin selectively inhibits dipeptidyl peptidase-4 (DPP-4), increasing endogenous incretin hormones (GLP-1 and GIP), which stimulate glucose-dependent insulin secretion and suppress glucagon release. Metformin, a biguanide, decreases hepatic glucose production, improves peripheral insulin sensitivity, and reduces intestinal glucose absorption. Together, these mechanisms lower fasting and post-meal blood glucose while carrying a relatively low risk of hypoglycaemia when used without insulin or sulfonylureas.

Usage Instructions for GALVUS MET-50MG/500MG-15 TABLETS

Take exactly as prescribed by your healthcare provider.

Swallow the tablet whole with or after food to reduce stomach upset.

Take the medicine at the same time each day for consistent blood sugar control.

Monitor blood glucose and attend regular follow-up appointments as advised.

Do not stop or adjust the dose without consulting your healthcare provider.

Medicinal Advantages of GALVUS MET-50MG/500MG-15 TABLETS

Dual-action therapy for improved glycaemic control.

Addresses multiple mechanisms involved in type 2 diabetes.

Fixed-dose combination may improve treatment adherence.

Suitable for adults requiring combination therapy with vildagliptin and metformin.

Supported by clinical evidence for use alongside lifestyle modifications.

NOTE: GALVUS MET-50MG/500MG-15 TABLETS is a prescription-only medicine. It is not indicated for type 1 diabetes or diabetic ketoacidosis. Kidney function should be assessed before starting treatment and monitored periodically.

Off-Label Uses of GALVUS MET-50MG/500MG-15 TABLETS

Healthcare professionals may occasionally consider this combination in individualized clinical situations based on patient needs and current evidence.

Individualized combination therapy for complex type 2 diabetes management.

Selected patients requiring treatment simplification from separate tablets.

Specialist-directed diabetes management strategies.

Disclaimer: Off-label uses should only occur under physician supervision and may not be approved in all countries.

Expert Advice for Optimal Use

Follow your prescribed diabetic meal plan.

Exercise regularly unless advised otherwise.

Monitor blood glucose as recommended.

Avoid excessive alcohol consumption.

Inform your healthcare provider about all medicines you take.

Attend routine kidney, liver, and HbA1c assessments.

Precautions

Cardiovascular Health

Maintain regular follow-up for cardiovascular risk assessment. Patients with established cardiovascular disease should continue comprehensive risk factor management.

Liver & Kidney Function

Kidney function should be evaluated before treatment and monitored periodically. Severe renal impairment is generally a contraindication for metformin-containing products. Liver impairment may also require avoidance or careful assessment.

Pregnancy & Breastfeeding

The use of this medicine during pregnancy or breastfeeding should be determined by a healthcare professional. Alternative diabetes management may be recommended during pregnancy.

Drug Interactions

Inform your healthcare provider about all prescription medicines, over-the-counter products, herbal supplements, and contrast dye procedures, as interactions may require monitoring or temporary treatment changes.

Existing Medical Conditions

Use cautiously in patients with kidney disease, liver disease, pancreatitis history, dehydration, severe infection, or conditions predisposing to lactic acidosis.

Storage Instructions

Store below 25°C or according to the package label.

Keep tablets in the original blister pack.

Protect from moisture and excessive heat.

Keep out of reach of children.

Do not use after the expiry date.

Frequently Asked Questions (FAQs)

Q: What is GALVUS MET-50MG/500MG-15 TABLETS used for?

A: It is prescribed to improve blood sugar control in adults with type 2 diabetes mellitus alongside diet and exercise.

Q: What are the active ingredients?

A: Each tablet contains Vildagliptin 50 mg and Metformin Hydrochloride 500 mg.

Q: Should I take this medicine with food?

A: Yes. It is generally recommended to take it with or after food to reduce gastrointestinal side effects.

Q: Can this medicine cause low blood sugar?

A: When used alone, the risk is generally low, but it may increase if combined with insulin or sulfonylureas.

Q: Is GALVUS MET-50MG/500MG-15 TABLETS suitable for type 1 diabetes?

A: No. It is indicated for adults with type 2 diabetes mellitus.

Q: Why are kidney function tests important?

A: Metformin is eliminated through the kidneys, so kidney function should be monitored to reduce the risk of serious complications such as lactic acidosis.

Q: Is this a prescription medicine?

A: Yes. GALVUS MET-50MG/500MG-15 TABLETS is a prescription-only antidiabetic medication that should be used under medical supervision.

Product Tags

GALVUS MET-50MG/500MG-15 TABLETS, Galvus Met 50/500, Vildagliptin 50 mg, Metformin 500 mg, Vildagliptin Metformin Tablet, DPP-4 Inhibitor, Biguanide, Type 2 Diabetes Medicine, Oral Antidiabetic Tablet, Blood Sugar Control, Diabetes Treatment, Prescription Diabetes Medicine, Glycaemic Control, HbA1c Management, Metformin Combination, Vildagliptin Tablet, Type 2 Diabetes Therapy, Diabetes Medication, Fixed Dose Combination, Antidiabetic Tablets